CARDIATEN
Food supplement declared in France, declaration No 2023-5-717, decision dated 16 May 2023
CARDIATEN (SYNPHONAT) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- SYNPHONAT
- Food business operator placing the product on the market
- Prom'innov Synphonat
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 Gélules
- Directions for use
- 1 gélule matin et soir au cours du repas
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants, Sous traitement médicamenteux, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol, Circulation sanguine et lymphatique
Declaration 194304, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Plectranthus barbatus Andrews | Racine | Extrait sec hydroalcoolique | 250 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
| Fibres solubles d'acacia | not declared |
Additives
Hydroxypropyl Méthyl Cellulose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
En aucun cas Cardiaten ne peut se substituer à un traitement médical à visée cardio-vasculaire sans l'accord du médecin qui a prescrit ce traitement. La prudence est conseillée aux personnes souffrant d'ulcère, la Forskoline pouvant dans certains cas accroître la sécrétion acide de l'estomac.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- CARDIATEN + SYNPHONAT, declared in 2023 : different composition: 1 ingredient(s) added, 0 missing
Brand : SYNPHONAT